Biology

Endonuclease

Oseltamivir

Virology

Biochemistry

Viral load

Environmental health

Coronavirus disease 2019 (COVID-19)

Placebo

Immunology

Alternative medicine

Regimen

Orthomyxoviridae

Enzyme

Population

Infectious disease (medical specialty)

Internal medicine

Clinical endpoint

Confidence interval

Medicine

Gastroenterology

Virus

Influenza A virus

Disease

Randomized controlled trial

Pathology

New England Journal of Medicine

Baloxavir marboxil is a selective inhibitor of influenza cap-dependent endonuclease. It has shown therapeutic activity in preclinical models of influenza A and B virus infections, including strains resistant to current antiviral agents.

Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents